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Allergic diseases are quite prevalent worldwide, 
and the incidence of allergy is increasing 
everywhere.1-7 Because allergic and immunologic 
processes overlap all organ systems, allergy is not 
always taught in medical schools as a separate 
subject. Indeed, lack of recognition of the 
specialty and of the need to teach about allergic 
and immunologic diseases results in allergy not 
being included at all in some medical school 
curricula.8 With an estimated 22% of the global 
population experiencing allergic and immunologic 
diseases, it is time to recognize and strengthen 
education in allergy and immunology.8  
The World Allergy Organization (WAO), an 
alliance of 74 national and regional allergy 
societies, created this consensus document to 
establish educational guidelines for worldwide 
application to help identify and correct allergy 
education and training deficiencies and to define 
appropriate competencies. In creating this 
consensus, it is recognized that each country has 
its own principles and goals in medical education 
at the undergraduate and postgraduate levels. This 
document defines what WAO considers medical 
practitioners should know to care appropriately 
for allergic patients. 
 
Background 
Diseases with an allergic etiology can affect many 
organ systems and occur in response to a wide 
variety of environmental factors. Allergic diseases 
are among the most common causes of chronic 
medical problems in both adults and children and 
are associated with high morbidity. They carry a 
large socioeconomic burden9-12 and can result in 
catastrophic anaphylaxis or fatal asthma attacks. 
Systemic hypersensitivity diseases include, among 
others, asthma, rhinoconjunctivitis, otitis, 
rhinosinusitis, urticaria, angioedema, eczema, 
food allergy, drug allergy, insect allergy, 
occupational allergic diseases, and anaphylaxis. 
Conventionally, allergic diseases have been 
divided into those associated with 
immunoglobulin E (IgE)-mediated hyper-
sensitivity and those involving other forms of 
hypersensitivity.13 As a medical specialty based 
on immunology, the allergy specialty (in some 
countries, called allergology) is concerned with 
prevention and diagnosis of the disease and 
management and rehabilitation of patients with 
allergic and related diseases. 
In some countries, the allergy specialty is 
combined with clinical immunology. Immune 
processes are fundamental to host defense. 
Malfunction of the immune system causes 
infections, reduces immune surveillance, leads to 
autoimmune phenomena, and impacts every organ 
system. Clinical immunology relates to immune 
system dysfunctions and immunologically 
mediated diseases, which by definition also 
include allergic diseases. In some other countries, 
allergy is positioned as a component of organ-
specific specialties such as dermatology, 
pulmonology, rheumatology, gastroenterology, 
and otorhinolaryngology; this positioning results 
in the specialty of allergy not always being 
recognized separately, and there may be no 
defined standardization of specialty training 
requirements for allergy. The WAO, as a global 
society, proposes that the best way to achieve a 
uniform quality level of care for the many 
millions of patients with allergic diseases is to 
define the key levels of competence required for 
both primary care clinicians and specialists who 
see patients who have allergic disorders. 
Given the very high prevalence of allergic 
diseases and the different medical systems 
throughout the world, patients may be managed 
by primary care physicians, internists or 
pediatricians (who in this document are grouped 
and defined as first-level care), by organ-based 
specialists who receive some specific training in 
allergy and/or immunology (defined in this 
document as second-level care), and/or by fully 
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trained specialists in allergy (third-level care). The 
WAO believes that an acceptable level of 
competence is required for all physicians who see 
allergy patients but who are not allergy specialists. 
A strong cooperative network with vertical links 
among physicians and other health care 
professionals at the first-level of care, organ-based 
specialists, and allergists is necessary for the 
optimal management of allergy patients.14,15 
Which physician sees which patient and to whom 
the patient is referred reflects both the availability 
of physicians specifically trained in allergy and 
immunology and the levels of competence of the 
referring physicians. It is essential for proper 
medical management that first- and second-level 
physicians are cognizant of the importance of an 
accurate diagnosis and the appropriate point at 
which to refer a patient to the next level of care. 
This document recommends the appropriate levels 
of competence necessary to manage allergic 
patients at each of the 3 defined levels and 
clarifies the appropriate time point in the disease 
for referral to an allergist. Once agreement upon 
these recommendations is achieved, the WAO 
will develop a more specific core curriculum and 
appropriate educational and training programs for 
medical students, residents in training, general 
practitioners, pediatricians, internists, organ-based 
specialists, and allergy specialists. 
It is proposed that the levels of competence for 
knowledge and skills be divided as described in 
the following paragraphs. 
 
First-Level Care 
This level includes recommendations for the 
knowledge and skills in allergy required for 
general practitioners, internists, and pediatricians. 
It also includes the knowledge and skills 
recommended for family practitioners and 
specialists in regions where organ-based 
specialists are not formally trained in the allergic 
aspects of their specialty and where trained 
allergists are not available. These 
recommendations also will apply to nurse 
practitioners and physicians' assistants if they are 
part of the health care community. 
Knowledge at this level should include a 
background in immunology obtained during 
medical training and should include an 
understanding of hypersensitivity mechanisms 
(Gell and Coombs I-IV); major mechanisms of 
host defense; the role of immunoglobulins in host 
defense; knowledge of lymphocyte function; the 
roles of leukocytes, especially eosinophils; and 
the functions of mast cells and basophils. 
Knowledge at the first level of care should include 
the following areas: 
1. Adequate clinical knowledge about the main 
allergic diseases, including rhinoconjunctivitis, 
rhinosinusitis, otitis, asthma, urticaria, 
angioedema, eczema, food allergy, insect 
allergy, anaphylaxis, drug allergy, and 
immunodeficiency, so that the diagnosis and 
treatment of both acute and chronic diseases are 
possible. Where feasible, such care should be 
carried out in collaboration with or with access 
to an allergist or an allergy referral center. 
2. Adequate knowledge in the interpretation of the 
main diagnostic allergy tests, skin prick tests, 
and serological tests for IgE and an 
understanding of pulmonary function test 
interpretation. Such training generally would 
not include competency in performing skin tests 
or the more sophisticated pulmonary function 
tests. 
3. Sufficient training to recognize patients with a 
level of persistence or severity, who experience 
exacerbations that are life affecting or who have 
difficult-to-manage allergic or immunologic 
disease who should be referred to an allergy 
specialist for evaluation and initiation of 
treatment before the disease advances to a 
severe or life-threatening stage. 
4. Immunotherapy (injective, sublingual) is 
performed by first-level physicians and other 
health care professionals in some countries. The 
WAO suggests that this is only appropriate as 
follows: 
A. The immunotherapy has been prescribed by a 
specialist. 
B. The first-level physician and other 
professionals have had adequate training in 
allergy and the recognition and management of 
anaphylaxis to provide this service safely. 
C. The location where immunotherapy is 
performed fulfills all the conditions for patient 
safety. The site where immunotherapy is 
performed should be equipped at a minimum 
with: 
a. oxygen and appropriate oxygen 
administration apparatus (mask or nasal device) 
and a manual or automatic respiration device; 
b. epinephrine to be administered intra-
muscularly or intravenously; 




f. colloid plasma expanders; 
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g. tourniquet to be placed above the site of 
injection of the vaccine; and 
h. there must be good access to full resuscitation 
facilities within the building or at a nearby 
hospital resuscitation unit. 
It is recommended that immunotherapy be 
initiated by an allergist or in a referral center and 
that a suitably trained first-level physician should 
provide maintenance treatment only. 
 
Second-Level Care 
Recommendations for key competencies at the 
second level of care apply to organ-based 
physicians such as those in dermatology, 
pulmonology, gastroenterology, otorhino-
laryngology, and rheumatology, who see allergy 
patients or act as allergy specialists, receiving 
referrals of allergy patients for diagnosis and 
management. In some health care systems, 
second-level care physicians receive training 
specifically in allergy. Knowledge at this level 
should include a fundamental background in 
allergy and immunology, an understanding of 
common allergic diseases, and the knowledge and 
skills to perform and interpret diagnostic tests to 
competently treat uncomplicated allergic diseases. 
In most countries, background training in allergy 
and immunology is obtained through rotations in 
allergy and immunology centers provided during 
residency in internal medicine or pediatrics. 
Thereafter, during the 2 to 3 years of training in 
specialties such as dermatology, pulmonology, 
otorhinolaryngology, gastroenterology, or 
rheumatology, adequate opportunities for 
instruction in allergy and immunology should be 
required. Organ-based specialists at this level 
should be required to have the knowledge base 
required of any first-level primary care physician, 
plus additional knowledge of host defense and 
clinical immunology and some understanding of 
cytokines and chemokines, genetics and 
environmental factors, and allergens and their 
relationship to human diseases.16,17  
The recommendations for second-level organ-
based specialists include the following: 
1. Broad clinical knowledge of major allergic and 
immune deficiency diseases. 
2. Knowledge sufficient to diagnose and treat the 
common uncomplicated cases of allergic 
disorders according to national and international 
guidelines. 
3. Adequate skills to perform and interpret allergy 
skin tests and the ability to interpret the other 
tests useful for the diagnosis, treatment, and 
prevention of allergic diseases. 
4. Administration of various forms of 
immunotherapy (in collaboration with allergy 
specialists and referral centers) after adequate 
training, but only if such therapy is performed in 
a setting where patient safety is ensured (see 
First-Level Care, 4.C.) 
 
Third-Level Care 
Third-level specialists are fully trained in allergy, 
having spent 2 or 3 years in training beyond 
either internal medicine or pediatric training. 
Such specialists will be expected to have a full 
knowledge and complete set of skills relating to 
all allergic diseases, and the competence to 
diagnose and treat in all areas. 
A core training needs to be acquired before the 
specific training in allergy. This training will be 
in internal medicine for those intending to deal 
with adult allergy patients, and in pediatrics for 
those intending to deal with children. In certain 
countries (the United States, for instance), 
training in allergy encompasses both pediatrics 
and internal medicine. 
 
Knowledge objectives 
1. Immune mechanisms involved in the 
development of immunologically mediated 
diseases and, in particular, allergic sensitization 
and disease formation. 
2. Genetic and environmental factors, including 
infectious diseases, involved in the genesis of 
allergic diseases. 
3. Pathogenesis of rhinoconjunctivitis, otitis, 
rhinosinusitis, asthma, atopic dermatitis, 
urticaria, and angioedema; drug and food 
allergy; insect allergy and anaphylaxis; and the 
concept that many allergic diseases are systemic 
in etiology. 
4. Relationship between tissue inflammation and 
repair. 
5. Mechanisms of IgE-mediated immediate- and 
late-phase allergic reactions. 
6. Mechanisms of non-IgE-mediated allergic 
reactions and other disorders in the differential 
diagnosis of allergic disease. These diseases 
include, but are not limited to, nonallergic 
rhinitis; drug-induced rhinitis; acute and chronic 
rhinosinusitis; nonallergic asthma; cough; 
bronchitis; non-IgE-mediated anaphylaxis; 
idiopathic urticaria; eczema; otitis; 
conjunctivitis; eosinophilic esophagitis, 
gastroenteritis, and colitis; celiaclike 
syndromes; food-induced enteropathies leading 
to gastroesophageal reflux, esophagitis, gastritis, 
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and gut motility disorders including 
constipation. 
7. National and global epidemiology of allergic 
diseases. 
8. Local airborne, contact, and occupational 
allergens. 
9. Classification and relative importance of all 
relevant allergens and their biologic 
characteristics, including heat, digestive 
stability, and cross-reactivity; understanding of 
local pollen counts and the characteristics of 
various aeroallergens and routes of allergen 
exposure. 
10. Therapy. 
A. Use and route of administration of 
antihistamines; mast cell stabilizers; 
bronchodilators; nasal, oral, topical, and 
inhaled glucocorticosteroids; decongestants; 
leukotriene modifiers; theophylline; adrenergic 
agonists; anticholinergics; mucolytics; 
antibiotics; adrenaline; and all other 
pharmacological and immunologic agents used 
to treat allergic and immunologic diseases. 
B. Use of emollients, antibiotics, topical 
glucocorticosteroids, immune modulators, and 
all other agents and techniques used to manage 
eczema and other allergic skin disorders. 
C. Use of immune modulators, such as specific 
allergen immunotherapy, monoclonal 
antibodies, including anti-IgE, and 
immunoglobulin replacement used to treat 
allergic and immunologic disorders, and 
knowledge of immune modulators that are 
being developed for clinical use in allergic and 
immunologic disorders. 
D. Methods and value of allergen-avoidance 
techniques. 
E. Avoidance diets and nutritional implications of 
dietary modification. 
F. Knowledge of national and international 
guidelines for the management of allergic and 
immunologic disorders in adults and children, 
with particular emphasis on safety and efficacy 
of all therapies. 
11. Investigation and management of adverse 
reactions to drugs and vaccines. 
12. Methods to measure cells and mediators in 
biologic fluids and tissues. 
13. Primary and secondary prevention of allergy, 
particularly in children. 
14. Understanding of the social and psychological 
issues associated with allergic diseases. 
15. Diagnosis and management of occupational 
allergic diseases. 
16. Methods to monitor home or work 
environments for allergens associated with 
allergic diseases. 
17. Understanding of environmental factors such 
as pollutants and occupational allergens and of 
viral respiratory tract infections that affect 
allergic sensitization and disease development. 
18. Recognition/diagnosis and treatment or 
appropriate referral of patients with humoral 
and cellular immunodeficiencies, hereditary and 
acquired complement deficiencies, and 
phagocytic disorders, depending upon whether 




1. Clinical skills 
A. Differential diagnosis, evaluation, and 
management or appropriate immunologic 





e. Atopic dermatitis 
f. Asthma, cough, dyspnea, and recurrent 
wheeze 
g. Acute and chronic urticaria, including 
physical urticarias 
h. Angioedema, including hereditary 
angioedema 
i. Anaphylaxis 
j. Food allergy and intolerance 
k. Drug and vaccine allergies or intolerance 
l. Insect allergy/hypersensitivity 
m. Oral allergy syndrome 
n. Latex allergy 
o. Occupational allergy, asthma, eczema 
p. Otitis 
q. Common variable immunoglobulin 
deficiency and related immunodeficiencies 
r. Primary immunodeficiencies 
s. Secondary immunodeficiencies 
t. Complement deficiencies 
u. Abnormalities of phagocytic cells 
2. Management of patients with multiple or 
complex allergies. 
3. Management of patients with multiple food 
allergies, requiring avoidance diets. 
4. Provision of allergen avoidance advice. 
5. Safe supervision of food and drug challenges. 
6. Assessment of patients for immunotherapy. 
Proper administration of immunotherapy 
including immunotherapy dose adjustment and 
management of complications. Supervision of 
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immunotherapy protocols. Recognition and 
management of allergic reactions associated 
with immunotherapy. 
7. Recognition of indications for and the skills to 
perform, interpret, and understand the 
limitations of skin prick, intradermal, patch, and 
delayed-type skin tests, and specific in vitro IgE 
antibody tests. 
8. Interpretation of natural allergen and 
environmental exposures. 
9. Evaluation and differentiation of non-IgE-
mediated hypersensitivity reactions. 
10. Investigation and management of behavioral 
problems related to allergic and immunologic 
diseases. 
11. Improvement of patient compliance with 
pharmacotherapy regimens through 
personalized disease management plans. 
12. Knowledge of drug desensitization protocols. 
13. Management in the community of patients at 
risk of anaphylactic reactions, incorporating an 
understanding of integrated care pathways. 
14. Diagnosis, treatment, and/or referral of 
primary and secondary humoral and cellular 
immunodeficiencies Such diseases include, but 
are not limited to Bruton agammaglobulinemia, 
severe combined immunodeficiency, thymic 
dysplasia, adenosine deaminase deficiency, 
Wiskott-Aldrich syndrome, ataxia 
telangiectasia, and various lymphocyte 
activation defects. 
15. Safe and effective administration of 
intravenous gamma globulin. 
16. Recognition and management or appropriate 
referral of hereditary and acquired complement 
deficiencies. 
17. Knowledge about and treatment/referral of 
phagocytic cell disorders, such as Chédiak-
Higashi syndrome, chronic granulomatous 
disease, leukocyte adhesion defects, and a 
variety of congenital and acquired neutropenias. 
 
Technical skills and knowledge objectives 
1. Performance and interpretation of skin prick, 
intradermal, patch tests, and delayed 
hypersensitivity tests. 
2. Performance of diagnostic testing for suspected 
drug, biologic, or vaccine allergy. 
3. Safe preparation and administration of 
immunotherapy vaccines. 
4. Performance of allergen provocation tests, such 
as nasal, conjunctival, bronchial, and oral 
challenges, and food and medication challenges. 
5. Performance of patch testing for contact 
dermatitis. 
6. Performance or knowledge of rhinoscopy and 
laryngoscopy, nasal endoscopy, acoustic 
rhinometry,* and rhinomanometry.*  
7. Performance of basic lung function testing, 
including spirometry and bronchial provocation 
tests (methacholine or histamine challenges, 
measurement of flow-volume loops and pulse 
oximetry, and prebronchodilator and 
postbronchodilator testing). 
8. Knowledge of how and when to measure 
exhaled nitric oxide, and how and when to 
perform whole-body plethysmography and 
impulse oscillometry.*  
9. Knowledge of how and when to use various 
tests to measure airway inflammation and/or 
constriction, including bronchodilator-induced 
bronchodilation, induced sputum,* and/or 
bronchial and bronchoalveolar lavage.*  
10. Assessment of environmental hazards in 
occupational allergy and knowledge of live 
insect sting challenges. 
11. Management of exclusion diets and 
provocation diets. 
12. Knowledge of and ability to interpret 
measurements of immune function, including 
serum immunoglobulin levels, IgG subclass 
levels, preimmunization and postimmunization 
antibody titers, isohemagglutinin titers, and 
other ancillary tests for use in the differential 
diagnosis of congenital or acquired humoral 
immunodeficiency. 
13. Measurement and interpretation of laboratory 
tests to diagnose hereditary angioedema and 
complement deficiencies. 
14. Measurement of phagocytic function. 
15. Interpretation of electrocardiograms, chest 
radiographs, computerized tomography scans 
and magnetic resonance images of the chest and 
sinuses, and interpretation of the main 
laboratory tests (blood, serum, microbiological, 
urine, and fecal tests). 
 
Attitudes 
1. Ability to work with colleagues in other 
disciplines. 
2. Appreciation of the scope and limitations of 
allergy testing. 
3. Appreciation of the limitations and problems 
created by so-called complementary medicine or 
alternative allergy practices. 
4. Understanding of the role of patient support 
groups and ability and willingness to work with 
patient support organizations. 
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5. Appreciation of all the issues relating to patient 
confidentiality and the ethical standards 
expected of all physicians. 
6. Understanding of research protocols, the ethics 
of experimental design, data analysis, 
biostatistics, good clinical practice, and good 
laboratory practice, and a willingness to become 
involved in either clinical or basic translational 
research. 
7. Knowledge of the country-specific legal 
framework for reporting of occupational 
diseases and assisting patients in obtaining 
compensation for occupational diseases. 
8. An ability to be a clinical decision maker, 
communicator, collaborator, manager, health 
care advocate, and scholar. 
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*Some of these skills should be at least taught and 
understood but may not be performed personally, in 
accordance with national guidelines and established 
practice parameters. 
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